Coherus Oncology, Inc. (CHRS) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,299
Total Return
-87.01%
CAGR
-33.52%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.90% |
| Median | -4.32% |
| Best | +136.52% |
| Worst | -58.12% |
| % of Windows Positive | 41.2% |
1-Year (252 Trading Days)
| Average | -36.28% |
| Median | -49.45% |
| Best | +142.59% |
| Worst | -79.98% |
| % of Windows Positive | 12.3% |
3-Year (756 Trading Days)
| Average | -87.15% |
| Median | -89.11% |
| Best | -70.89% |
| Worst | -96.05% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -96.47% |
| Average Drawdown | -67.06% |
| Drawdown Duration | 1103 Trading Days (Unrecovered) |
| Sortino Ratio | -0.10 |
| Calmar Ratio | -0.35 |
| CVaR (5%) | -11.35% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +26.76% (+129.98% ann.) | +$2676.07 | $0.00 | $0.00 | $0.00 |
| 2025 | +2.90% | +$289.85 | $0.00 | $0.00 | $0.00 |
| 2024 | -58.56% | $5855.85 | $0.00 | $0.00 | $0.00 |
| 2023 | -57.95% | $5795.46 | $0.00 | $0.00 | $0.00 |
| 2022 | -50.38% | $5037.59 | $0.00 | $0.00 | $0.00 |
| 2021 | -8.17% | $817.03 | $0.00 | $0.00 | $0.00 |
| 2020 | -3.47% | $347.13 | $0.00 | $0.00 | $0.00 |
| 2019 | +98.95% | +$9895.04 | $0.00 | $0.00 | $0.00 |
| 2018 | +2.84% | +$284.08 | $0.00 | $0.00 | $0.00 |
| 2017 | -68.74% | $6873.89 | $0.00 | $0.00 | $0.00 |
| 2016 | +22.60% | +$2260.45 | $0.00 | $0.00 | $0.00 |
| 2015 | +40.69% | +$4068.63 | $0.00 | $0.00 | $0.00 |
| 2014 partial | +29.42% (+454.39% ann.) | +$2942.11 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | November 6, 2014 – February 19, 2020 | +78.43% | +11.57% | +$7842.98 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -36.76% | -99.46% | $3675.56 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +2.58% | +4.19% | +$258.30 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +2.30% | +2.19% | +$230.47 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -62.25% | -64.46% | $6225.09 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -86.72% | -66.35% | $8671.78 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +71.43% | +41.00% | +$7142.93 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.